These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8416750

  • 1. Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines.
    Zakut R, Topalian SL, Kawakami Y, Mancini M, Eliyahu S, Rosenberg SA.
    Cancer Res; 1993 Jan 01; 53(1):5-8. PubMed ID: 8416750
    [Abstract] [Full Text] [Related]

  • 2. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D, Liénard D, Waanders G, Rimoldi D, Cerottini JC, Romero P.
    Cancer Res; 1997 Feb 15; 57(4):735-41. PubMed ID: 9044853
    [Abstract] [Full Text] [Related]

  • 3. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ, Martin D, Elder E, Storkus WJ, Lotze MT.
    Clin Cancer Res; 1996 Jan 15; 2(1):87-95. PubMed ID: 9816095
    [Abstract] [Full Text] [Related]

  • 4. MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte.
    Lethé B, van der Bruggen P, Brasseur F, Boon T.
    Melanoma Res; 1997 Aug 15; 7 Suppl 2():S83-8. PubMed ID: 9578421
    [Abstract] [Full Text] [Related]

  • 5. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R, Ronteltap C, Heuveling M, Debets R, Bolhuis R.
    Gene Ther; 2005 Jan 15; 12(2):140-6. PubMed ID: 15496961
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lysis of human chondrosarcoma cells by cytolytic T lymphocytes recognizing a MAGE-A3 antigen presented by HLA-A1 molecules.
    Bluman EM, Coulie PG, Xiaojuan S, Machan J, Lin C, Meitner PA, Block JA, Terek RM.
    J Orthop Res; 2007 May 15; 25(5):678-84. PubMed ID: 17290408
    [Abstract] [Full Text] [Related]

  • 16. Efficient induction of cytotoxic T lymphocytes specific to hepatocellular carcinoma using HLA-A2-restricted MAGE-n peptide in vitro.
    Dong HL, Sui YF, Li ZS, Qu P, Wu W, Ye J, Zhang XM, Lu SY.
    Cancer Lett; 2004 Aug 10; 211(2):219-25. PubMed ID: 15219945
    [Abstract] [Full Text] [Related]

  • 17. MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.
    Toso JF, Oei C, Oshidari F, Tartaglia J, Paoletti E, Lyerly HK, Talib S, Weinhold KJ.
    Cancer Res; 1996 Jan 01; 56(1):16-20. PubMed ID: 8548758
    [Abstract] [Full Text] [Related]

  • 18. Development and immunophenotyping of squamous cell carcinoma xenografts: tools for translational immunology.
    Lin W, Zhang X, Chen Z, Borson N, Voss S, Sanderson S, Murphy L, Wettstein P, Strome SE.
    Laryngoscope; 2005 Jul 01; 115(7):1154-62. PubMed ID: 15995500
    [Abstract] [Full Text] [Related]

  • 19. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen.
    Hoon DS, Yuzuki D, Hayashida M, Morton DL.
    J Immunol; 1995 Jan 15; 154(2):730-7. PubMed ID: 7814879
    [Abstract] [Full Text] [Related]

  • 20. Expression of MAGE-1, MAGE-2 and MAGE-3 genes in human gastric carcinomas; lack of evidence for cytotoxic effects in cases with simultaneous expression of MAGE-3 and HLA-A2.
    Ofuji S, Ikeda M, Tsujitani S, Ikeguchi M, Kaibara N, Yuasa I, Mitsuya K, Katoh M, Ito H.
    Anticancer Res; 1998 Jan 15; 18(5B):3639-44. PubMed ID: 9854470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.